|
|
Volumn 5, Issue 3, 2006, Pages 177-
|
|
Academia given a helping hand in drug development
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPHETAMINE;
BETA1A INTERFERON;
HUMAN GROWTH HORMONE;
INSULIN;
LOW MOLECULAR WEIGHT HEPARIN;
METHYLPHENIDATE;
NATALIZUMAB;
OMNITROPE;
PLACEBO;
RIMONABANT;
TROGLITAZONE;
WARFARIN;
XIMELAGATRAN;
ATTENTION DEFICIT DISORDER;
AUSTRALIA;
BIOTECHNOLOGY;
BRAIN DISEASE;
CARDIOVASCULAR RISK;
CLINICAL STUDY;
CLINICAL TRIAL;
CONSUMER;
COST BENEFIT ANALYSIS;
DEEP VEIN THROMBOSIS;
DIABETES MELLITUS;
DRUG APPROVAL;
DRUG COST;
DRUG FATALITY;
DRUG INDUSTRY;
DRUG LEGISLATION;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG RESEARCH;
DRUG SAFETY;
DRUG WITHDRAWAL;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
GOOD MANUFACTURING PRACTICE;
HEALTH CARE ORGANIZATION;
HEALTH SERVICE;
HUMAN;
LIVER DYSFUNCTION;
LIVER INJURY;
LIVER TOXICITY;
MEDICAL LITERATURE;
NOTE;
OBESITY;
PRACTICE GUIDELINE;
PRESCRIPTION;
PRIORITY JOURNAL;
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
STROKE;
UNITED KINGDOM;
UNITED STATES;
CLINICAL TRIALS;
DRUG DESIGN;
HUMANS;
RESEARCH;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 33644748228
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd1993 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|